Search

everythinglearnresearchcommunity

for

Search:↓

Occipital scalp affects female hair loss; terminal/vellus ratio helps diagnose androgenetic alopecia.

Alopecia areata is a common autoimmune condition causing varying hair loss, diagnosed by specific patterns of inflammation around hair follicles, with several treatment options available.

Gamma-rays exposure during the resting phase of hair growth can damage hair regeneration and color in mice.

Hair loss in Cronkhite-Canada syndrome may be caused by autoimmune factors, not just stress or malabsorption.

The study concludes that traction alopecia, caused by hair styling, can help understand telogen effluvium, a condition of excessive hair loss.

Other common signs, not just the well-known immune cells around hair bulbs, are important for diagnosing hair loss from alopecia areata.

The main causes of diffuse hair loss in women are telogen effluvium and androgenetic alopecia, often related to stress and iron deficiency.

The condition called 'acute diffuse and total alopecia of the female scalp' is actually a known condition named alopecia areata incognita.

Eosinophilic infiltrate is not a reliable indicator for diagnosing chronic alopecia areata.

TDM10842, a thyroid hormone receptor activator, was found to effectively promote hair growth in mice.

Prostaglandin helps regenerate hair follicles after radiation damage.

Gamma-ray exposure can cause long-lasting damage to hair follicles, affecting hair structure and color.

Gamma rays did not change hair follicle density but increased white and hypopigmented hairs in mice.

The research identified genes and pathways important for sheep wool growth and shedding.

A woman's hair turned white after taking a cancer drug called dasatinib.

Sorafenib may cause hair loss in a way similar to alopecia areata.

A critically ill boy experienced hair loss likely due to the stress of his medical treatments, but his hair regrew completely in 1.5 months.

FGF18 treatment during hair's resting phase can protect against hair loss from radiation.

Examining scalp tissue under a microscope helps diagnose and understand hair loss diseases.

The study found that Short Anagen Syndrome results in short hair growth not due to hair fragility, and hair may grow longer after puberty.

Obese mice with a leptin gene mutation have a longer resting phase in their hair cycle, which may help understand certain hair loss conditions.

The "color-transition sign" helps tell apart alopecia areata incognita from telogen effluvium by looking at hair color changes.

Tiny particles from stem cells help activate hair growth cells and encourage hair growth in mice without being toxic.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Oral minoxidil effectively reduces hair shedding in women with CTE, with no major side effects.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

GasderminA3 is important for normal hair cycle transitions by controlling Wnt signaling.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Hair is thinner near the scalp in acute hair shedding conditions.

Acute telogen effluvium can be resolved by addressing causes, but chronic telogen effluvium is harder to treat.